Federal health officials on Wednesday announced the launch of a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows a certain amount of THC in products.

CMS is piloting a new program that permits some clinicians to offer certain hemp-derived products to Medicare patients as part of their care plans. The new Substance Access Beneficiary Engagement Incentive is part of CMS’ Innovation Center model-testing framework,

A new incentive could allow participants in certain federal insurance programs to receive coverage of up to $500 worth of hemp products each year. The new program would go into effect beginning

Georgia lawmakers face a Thursday deadline to pass a bill that would ban most synthetic hemp products.

A new measure passed by Congress will effectively make hemp illegal nationwide, but Minnesota is pressing ahead with the licensing process.

The Huntsville City Council will hold a public hearing and vote on new rules regulating the sale of hemp products within the city limits at its meeting Thursday night, The council’s meeting is at 5:30 p.